98-21289. The Centers for Disease Control and Prevention (CDC); Meeting  

  • [Federal Register Volume 63, Number 153 (Monday, August 10, 1998)]
    [Notices]
    [Pages 42637-42638]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-21289]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    The Centers for Disease Control and Prevention (CDC); Meeting
    
        Name: Advisory Committee on Immunization Practices (ACIP) 
    Working Group on Influenza.
        Times and Dates: 8 a.m.-5:30 p.m., September 1, 1998; 8 a.m.-12 
    noon, September 2, 1998.
        Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
    Atlanta, Georgia 30333.
        Status: Open to the public, limited only by the space available.
        Purpose: The Committee is charged with advising the Director, 
    CDC, on the appropriate uses of immunizing agents. The Influenza 
    Working Group was formed to assist the Committee in expanding the 
    current ACIP influenza immunization recommendations to include the 
    use of new influenza vaccines and antiviral agents expected to be 
    licensed by the Food and Drug Administration within the next two 
    years.
        Matters to be Discussed: The agenda will include presentations 
    on the potential health benefits of vaccinating healthy adults 
    against influenza; economic studies on vaccinating healthy adults 
    against influenza; a study on the vaccination of healthy women; the 
    cost effectiveness of vaccinating healthy adult workers; modeling 
    the economics of vaccinating healthy adults against influenza; 
    comments from the Food and Drug Administration, Council of State and
    
    [[Page 42638]]
    
    Territorial Epidemiologists, National Institutes of Health, American 
    College of Physicians, American Academy of Pediatrics, and the 
    Pharmaceutical Manufacturers of America; and a review of the 
    licensed and new influenza antiviral agents.
        Contact Person for More Information: Gloria A. Kovach, Committee 
    Management Specialist, CDC (16-4346), 1600 Clifton Road, NE, 
    Mailstop D50, Atlanta, Georgia 30333, telephone 404/639-7250.
        Dated: July 30, 1998.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 98-21289 Filed 8-7-98; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
08/10/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
98-21289
Dates:
8 a.m.-5:30 p.m., September 1, 1998; 8 a.m.-12 noon, September 2, 1998.
Pages:
42637-42638 (2 pages)
PDF File:
98-21289.pdf